SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Appendix 3Y

27 Jun 2012 10:17

RNS Number : 2494G
Coal of Africa Limited
27 June 2012
 



Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

This announcement replaces that of 07:11 on 29 July 2011. The replacement is to reflect the fact that the price per share disposed of was 73 pence and not 73 cents.

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

 

Name of entity Coal of Africa Limited

ABN 98 088 905 388

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director

Simon James Farrell

Date of last notice

30 June 2011

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Direct or indirect interest

Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

Newcove International Inc.

 

Mr Farrell is a director and shareholder of Newcove International Inc.

Date of change

26 June 2012

No. of securities held prior to change

Direct interest

5,000,000 options exercisable at $1.25 each on or before 30 September 2012.

3,000,000 options exercisable at $2.74 each on or before 30 November 2014.

Indirect interest

2,871,791 fully paid ordinary shares.*

*Shares are held by Newcove International Inc, of which Mr Farrell is a director and shareholder.

Class

Shares

Number acquired

1,833,150

Number disposed

Nil

 

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

Nil

No. of securities held after change

Direct interest

5,000,000 options exercisable at $1.25 each on or before 30 September 2012.

3,000,000 options exercisable at $2.74 each on or before 30 November 2014.

Indirect interest

4,704,941 fully paid ordinary shares.*

 

*Shares are held by Newcove International Inc, of which Mr Farrell is a director and shareholder.

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Issue of shares to Directors as approved at the general meeting of shareholders held on 22 June 2012.

 

Part 2 - Change of director's interests in contracts

 

Detail of contract

N/A

Nature of interest

 

 

Name of registered holder

(if issued securities)

 

Date of change

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

 

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

 

Interest after change

 

 

 

 

 

Part 3 - +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

 

If prior written clearance was provided, on what date was this provided?

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEANKXAFSAEEF
Date   Source Headline
31st Oct 20128:00 amRNSDespatch of Annual Report and Notice of AGM
1st Oct 20127:15 amRNSAnnual Consolidated Financial Statements
1st Oct 20127:00 amRNSProposed US$100 Million Placement with BHE
1st Oct 20127:00 amRNSAnnual Financial Commentary and Project Update
1st Oct 20127:00 amRNSMakhado Strategic Partner Update
28th Sep 201210:04 amRNSCommencement of Legal Action proceedings
26th Sep 20127:00 amRNSInterim Results for 30 June 2012
25th Sep 201211:12 amRNSStrike action at Mooiplaats
17th Sep 20127:00 amRNSNon-Executive Director Changes
14th Sep 20129:11 amRNSHolding(s) in Company
13th Sep 20127:00 amRNSAppendix 3B
13th Sep 20127:00 amRNSIssue of Shares
11th Sep 201212:26 pmRNSResult of EGM
17th Aug 20124:40 pmRNSSecond Price Monitoring Extn
17th Aug 20124:35 pmRNSPrice Monitoring Extension
13th Aug 20121:11 pmRNSHolding(s) in Company
13th Aug 20127:00 amRNSInitial Directors' Interest Notice
13th Aug 20127:00 amRNSAppendix 3X
13th Aug 20127:00 amRNSAppendix 3X
13th Aug 20127:00 amRNSNotice of General Meeting
7th Aug 20128:42 amRNSAppendix 3B
7th Aug 20128:42 amRNSIssue of Shares
7th Aug 20128:42 amRNSFinal Director's Interest Notice
7th Aug 20128:41 amRNSFinal Director's Interest Notice
7th Aug 20128:41 amRNSFinal Director's Interest Notice
7th Aug 20128:40 amRNSFinal Director's Interest Notice
6th Aug 20126:21 pmRNSPlacing and Board changes
1st Aug 20127:00 amRNSAppendix 5B
1st Aug 20127:00 amRNSQuarterly Report
31st Jul 201210:07 amRNSHolding(s) in Company - Replacement
30th Jul 20125:34 pmRNSHolding(s) in Company
30th Jul 201211:09 amRNSHolding(s) in Company
25th Jul 20123:15 pmRNSExercise of Options and Issue of Equity
19th Jul 20127:00 amRNSIssue of Shares
19th Jul 20127:00 amRNSAppendix 3B
18th Jul 20127:00 amRNSDebt and Equity Financing Package
5th Jul 20127:00 amRNSAppendix 3Y
2nd Jul 20124:27 pmRNSHolding(s) in Company
27th Jun 201210:20 amRNSAppendix 3Y
27th Jun 201210:17 amRNSAppendix 3Y
27th Jun 201210:11 amRNSAppendix 3Y
27th Jun 201210:08 amRNSAppendix 3Y
27th Jun 201210:03 amRNSAppendix 3Y
26th Jun 201211:20 amRNSIssue of Shares - Replacement
26th Jun 201210:20 amRNSIssue of Shares
26th Jun 201210:20 amRNSAppendix 3B
22nd Jun 20123:40 pmRNSChange of Name of Nominated Adviser
22nd Jun 20123:02 pmRNSResult of EGM
18th Jun 20121:55 pmRNSResult of AGM
18th Jun 20127:00 amRNSMakhado Project Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.